Literature DB >> 22311131

"Inherent limitations" in donors: control matched study of consequences following a right hepatectomy for living donation and benign liver lesions.

Jacques Belghiti1, Guido Liddo, Vikram Raut, Magaly Zappa, Safi Dokmak, Valérie Vilgrain, François Durand, Fédérica Dondéro.   

Abstract

OBJECTIVE: The aim of this study was to identify "inherent limitations" in healthy donors who are responsible for donor morbidity after right hepatectomy (RH) for adult-to-adult living donor liver transplantation (ALDLT).
BACKGROUND: Right hepatectomy for ALDLT remains a challenging procedure without significant improvement in morbidity over time. This suggests some "inherent limitations" in healthy individuals, which are beyond the recent improvements in the donor evaluation and selection process and refinements in surgical technique during the learning curve.
METHODS: To identify response of RH in ALDLT, we prospectively studied 32 patients requiring an RH for benign liver lesions (BL), matched with 32 living donors (LD) operated by same team. All patients underwent liver volume evaluation by computed tomographic (CT) volumetry preoperatively and 1 week after RH, postoperative complications graded with Clavien's system.
RESULTS: The comparison (LD vs BL) showed that remnant liver volume (RLV) on preoperative CT volumetry was higher in the BL group (450 ± 150 vs 646 ± 200 mL, P < 0.001) representing 31% ± 7% in LD group versus 36% ± 7% of the total liver volume in BL group (P = 0.03). On postoperative day 7, the RLV was similar in the 2 groups (866 ± 162 vs 941 ± 153 mL) resulting from a significantly higher regeneration rate in the LD group (89% vs 55%, P = 0.009). Overall complications rate was lower in the BL group (46% vs 21%, P = 0.035).
CONCLUSIONS: Right hepatectomy in LDLT induces a more severe deprivation of liver volume than in BL, which induce an accelerated regeneration. Accelerated regeneration could represent "inherent limitation" in healthy donors that makes them more vulnerable for postoperative complications.

Entities:  

Mesh:

Year:  2012        PMID: 22311131     DOI: 10.1097/SLA.0b013e3182472152

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

1.  Is it worth discussing the feasibility of deceased donor liver transplantation in centers with a strong experience in living donor liver transplantation?

Authors:  François Durand
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

2.  Bloodless donor hepatectomy in living donor liver transplantation: counterclockwise liver rotation and early hanging maneuver.

Authors:  Hiroshi Sadamori; Takahito Yagi; Susumu Shinoura; Yuzo Umeda; Ryuichi Yoshida; Daisuke Satoh; Daisuke Nobuoka; Masashi Utsumi; Kazuhiro Yoshida; Toshiyoshi Fujiwara
Journal:  J Gastrointest Surg       Date:  2012-05-10       Impact factor: 3.452

3.  Hypertrophy of the Left Liver in Patients with Large Tumors in the Right Liver.

Authors:  Yoshimi Nakayama; Yoichi Ishizaki; Jiro Yoshimoto; Hiroyuki Sugo; Hiroshi Imamura; Seiji Kawasaki
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

Review 4.  Laparoscopic liver resection for living donation: where do we stand?

Authors:  François Cauchy; Lilian Schwarz; Olivier Scatton; Olivier Soubrane
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 5.  New paradigms in post-hepatectomy liver failure.

Authors:  Nicolas Golse; Petru O Bucur; René Adam; Denis Castaing; Antonio Sa Cunha; Eric Vibert
Journal:  J Gastrointest Surg       Date:  2012-11-18       Impact factor: 3.452

6.  Risk of venous congestion in live donors of extended right liver graft.

Authors:  Arnold Radtke; George Sgourakis; Ernesto P Molmenti; Susanne Beckebaum; Vito R Cicinnati; Hartmut Schmidt; Heinz-Otto Peitgen; Christoph E Broelsch; Massimo Malagó; Tobias Schroeder
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

7.  Improved liver function after portal vein embolization and an elective right hepatectomy.

Authors:  Raphael P H Meier; Christian Toso; Sylvain Terraz; Romain Breguet; Thierry Berney; Axel Andres; Anne-Sophie Jannot; Laura Rubbia-Brandt; Philippe Morel; Pietro E Majno
Journal:  HPB (Oxford)       Date:  2015-09-08       Impact factor: 3.647

8.  Risk Factors Associated with Increased Morbidity in Living Liver Donation.

Authors:  Helry L Candido; Eduardo A da Fonseca; Flávia H Feier; Renata Pugliese; Marcel A Benavides; Enis D Silva; Karina Gordon; Marcelo Gama de Abreu; Jaume Canet; Paulo Chapchap; Joao Seda Neto
Journal:  J Transplant       Date:  2015-12-15

Review 9.  Somatostatin and the "Small-For-Size" Liver.

Authors:  Amelia J Hessheimer; Lilia Martínez de la Maza; Farah Adel Al Shwely; Arlena Sofía Espinoza; Fabio Ausania; Constantino Fondevila
Journal:  Int J Mol Sci       Date:  2019-05-22       Impact factor: 5.923

Review 10.  Post hepatectomy liver failure - A comprehensive review of current concepts and controversies.

Authors:  S Ray; N N Mehta; A Golhar; S Nundy
Journal:  Ann Med Surg (Lond)       Date:  2018-08-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.